U.S. Interactive Media and Services Stock News

NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Is It Too Late To Reassess Qorvo (QRVO) After Its Recent Share Price Rebound?

If you are wondering whether Qorvo at around US$82.90 still offers value or is pricing in too much optimism already, you are not alone. The stock has returned 0.8% over the last 7 days and 6.1% over the last 30 days, while the year to date return sits at a 3.9% decline and the 1 year return is 14.0%. This compares to a 19.3% decline over 3 years and a 51.6% decline over 5 years. Recent coverage of Qorvo has focused on its role within the semiconductor sector and how investor expectations are...
NYSE:PBH
NYSE:PBHPharmaceuticals

Assessing Prestige Consumer Healthcare (PBH) Valuation After Mixed Returns And An 11% Intrinsic Value Discount

Recent Share Performance Snapshot Prestige Consumer Healthcare (PBH) has seen mixed share performance recently, with a 1 day return of roughly a 1.3% decline, a flat result over the past week, and gains over the month and past 3 months. Over longer periods the picture is split, with a 13.2% gain year to date and a 14.9% total return over 3 years, set against an 18.2% total return decline over the past year. See our latest analysis for Prestige Consumer Healthcare. At a share price of $69.30,...
NYSE:DK
NYSE:DKOil and Gas

Is It Too Late To Consider Delek US Holdings (DK) After A 146% One Year Surge?

If you are wondering whether Delek US Holdings is still attractively priced after its recent run, this breakdown will help you frame the current share price against what the business might be worth. The stock last closed at US$38.11, with returns of 10.9% over 7 days, 29.1% over 30 days, 28.0% year to date and 146.1% over the past year. These moves naturally raise questions about both upside potential and changing risk. Recent coverage of Delek US Holdings has focused on its position in the...
NYSE:MUR
NYSE:MUROil and Gas

Do Murphy Oil’s Ivory Coast Dry Holes Reframe Its Exploration Risk Strategy for Investors (MUR)?

Murphy Oil Corporation recently reported that its second exploration well offshore Côte d'Ivoire, Caracal-1X in Block CI-502, reached 8,534 feet but will be plugged and abandoned as a dry hole after only encountering hydrocarbon shows. Despite back-to-back dry holes in its three-well Ivory Coast campaign, Murphy and PETROCI are pressing ahead with the Bubale-1X well, which targets a different geological play and will help reassess the remaining potential of the company’s West African...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Does QCR Holdings' (QCRH) Higher Dividend Reveal a New Capital Allocation Playbook?

In February 2026, QCR Holdings, Inc. announced that its Board of Directors approved a cash dividend of US$0.10 per share, payable on April 3, 2026, to shareholders of record as of March 19, 2026, raising the quarterly payout from US$0.06 per share. This sizable step-up in the regular dividend highlights management’s emphasis on returning capital to shareholders while signaling confidence in the company’s financial position. Next, we’ll examine how this materially higher quarterly dividend...
NasdaqGS:CCB
NasdaqGS:CCBBanks

Coastal Financial (CCB) Valuation After Earnings Miss And Rising Regional Bank Credit Concerns

Coastal Financial (CCB) is back in focus after its latest quarter, where revenue and net interest income missed expectations, and investors weighed those results against rising credit risk worries for regional banks. See our latest analysis for Coastal Financial. Those weak quarterly numbers, together with sector wide credit risk worries, have coincided with a sharp swing in sentiment, with a 22.5% decline in the 30 day share price return and a 34.5% year to date share price return, even...
NYSE:KAI
NYSE:KAIMachinery

Kadant (KAI) Valuation Check After 2025 Results And 2026 Guidance Update

Kadant (KAI) recently reported fourth quarter and full year 2025 results, alongside fresh 2026 guidance, giving investors an updated view of current performance and what management expects for the year ahead. See our latest analysis for Kadant. The earnings release and 2026 guidance landed after a strong run in the share price, with a 90 day share price return of 22.21% and year to date share price return of 18.43% from the latest close of US$339.17. This is despite the 1 year total...
NYSE:TIC
NYSE:TICProfessional Services

Assessing TIC Solutions (NYSE:TIC) Valuation After Recent Share Price Pullback And NV5 Integration Deal

TIC Solutions (TIC) has drawn investor attention after recent trading left the stock around $9.47, with declines over the past week and month, and a roughly flat move over the past 3 months. See our latest analysis for TIC Solutions. Those recent share price declines, including the 3.86% 1 day move and 6.24% 30 day share price return, sit within a weaker picture overall, with a 1 year total shareholder return of 23.38%. If TIC Solutions’ recent pullback has you scanning for other ideas, it...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

Is Alkami Technology (ALKT) Pricing Look Attractive After A 46% One-Year Share Price Slide

If you are wondering whether Alkami Technology is starting to look interesting at its current share price, this article will walk through what that price actually implies about the company. The stock last closed at US$16.55, with returns of a 2.8% decline over 7 days, a 21.9% decline over 30 days, a 27.1% decline year to date and a 46.4% decline over the past year, while the 3 year return sits at 7.1%. These moves come as investors continue to track company specific developments and the...
NYSE:YUMC
NYSE:YUMCHospitality

Yum China Holdings (YUMC) Valuation After Strong 2025 Results Raised 2026 Outlook And Insider Stock Sale

Yum China Holdings (YUMC) is back in focus after reporting Q4 and full year 2025 results that highlighted revenue and margin gains, followed by raised 2026 growth expectations and a sizable insider stock sale. See our latest analysis for Yum China Holdings. At a share price of US$54.91, Yum China’s recent 30 day share price return of 11.11% and year to date gain of 13.99% suggest momentum has picked up, even though the 3 year and 5 year total shareholder returns of 7.32% and 3.21% declines...
NYSE:CPRI
NYSE:CPRILuxury

Is Capri Holdings (CPRI) Blending CFO and COO Roles to Recast Its Transformation Ambitions?

Capri Holdings has appointed Tyler Reddien as Chief Financial Officer and Chief Operating Officer, effective March 30, 2026, with interim CFO Rajal Mehta returning to his prior role as Michael Kors brand CFO. The consolidation of finance and operations leadership under Reddien, who brings experience from The Body Shop, Natura &Co, Hertz, and United Airlines, could influence how Capri pursues performance improvement and transformation across its global portfolio. Next, we’ll examine how...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Huntington Bancshares Merger With Cadence Tests Integration And Value Case

Huntington Bancshares has finalized its merger with Cadence Bank, creating a larger regional banking platform. The bank is preparing a major customer account integration that will bring Cadence customers onto Huntington’s systems. The combined bank expands Huntington’s reach in Texas and the Southeast, with operational and customer changes expected as integration progresses. Huntington Bancshares, ticker NasdaqGS:HBAN, is stepping into its next phase as a combined institution after closing...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams Sonoma’s GreenRow Adds Naturepedic To Support Organic Sleep Valuation Narrative

Naturepedic has entered an exclusive retail partnership with GreenRow, a Williams-Sonoma (NYSE:WSM) brand. The collaboration introduces a dedicated assortment of certified organic sleep products for GreenRow customers. The new Aurora Mattress is debuting as part of the deal, expanding Naturepedic's organic mattress lineup. For Williams-Sonoma, known for premium home and kitchen brands, this move adds more certified organic, healthier sleep options to the GreenRow offering. It aligns with...
NYSE:DOCN
NYSE:DOCNIT

Is It Time To Reconsider DigitalOcean (DOCN) After Recent Share Price Volatility

If you are wondering whether DigitalOcean Holdings is still attractively priced after its recent run, you are not alone. This article will help you weigh what the current share price really reflects. The stock most recently closed at US$56.06, with returns of 1.5% over the last 30 days, 14.5% year to date, and 30.8% over the past year. The last 7 days showed an 11.9% decline that may have changed how some investors see the risk and reward trade off. Recent news coverage has focused on...
NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura Dividend Policy Rises As San Gabriel Nears Full Contribution

Buenaventura (NYSE:BVN) has approved a higher dividend payout policy, supported by strong operating cash flow. The Board also cleared a higher dividend distribution to shareholders under the new framework. The San Gabriel project is approaching completion, with ramp up reported as close to finished. For you as an investor, the combination of a higher dividend payout policy and a near complete San Gabriel ramp up is a key development for Compañía de Minas Buenaventura, a precious metals...
NYSE:OGE
NYSE:OGEElectric Utilities

Is It Too Late To Consider OGE Energy (OGE) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...
NasdaqGS:LZ
NasdaqGS:LZProfessional Services

Reassessing LegalZoom (LZ) After A 31% One‑Year Share Price Decline

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Assessing PTC Therapeutics (PTCT) Valuation After Contrasting Quarterly Loss And Full Year Profit Turnaround

PTC Therapeutics (PTCT) shares are in focus after the company released fourth quarter and full year 2025 results, which combined weaker quarterly figures with a sharp full year swing to positive earnings. See our latest analysis for PTC Therapeutics. At a share price of US$68.19, PTC Therapeutics has recently seen weaker short term share price returns, with a 30 day share price return of 9.72% and a year to date share price return of 11.14%. Its 1 year total shareholder return of 23.4% and 3...
NasdaqGS:FULT
NasdaqGS:FULTBanks

A Look At Fulton Financial (FULT) Valuation After Recent Share Price Pullback

Fulton Financial (FULT) is back on investor radars after a recent share pullback, with the stock closing at US$20.45. That is shifting sentiment toward its valuation and the bank’s underlying financial profile. See our latest analysis for Fulton Financial. The recent 5.5% one day share price decline and 8.7% 7 day share price return dip sit against a 90 day share price return of 11.2% and 1 year total shareholder return of 7.3%. This suggests that longer term momentum is still intact despite...
NYSE:BKU
NYSE:BKUBanks

Is Slowing Net Interest Income Forcing BankUnited (BKU) To Rethink Its Expansion Ambitions?

In recent months, BankUnited reported solid quarterly results and continued investments in digital capabilities and new markets, even as its net interest income growth trailed the broader banking industry and analysts projected a weaker efficiency ratio ahead. This tension between operational expansion and concerns about slowing profitability has led some analysts to question how durable BankUnited’s current growth ambitions may be. Next, we’ll examine how these concerns about slowing net...
NYSE:DELL
NYSE:DELLTech

Dell’s Record AI Results And Capital Returns Tested Against Valuation Upside

Dell Technologies (NYSE:DELL) reported record financial results, supported by a $43b AI server backlog. The company set ambitious AI growth targets and announced a $10b increase to its share repurchase authorization. Dell raised its dividend by 20% and introduced the rugged, liquid cooled PowerEdge XR9700 server for edge AI workloads. The company expanded partnerships, including a deeper alliance with Unisys and an extended collaboration with McLaren Racing in Formula 1. For investors...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Q4 2025 Highlights Shift Toward Higher Value Pharma Segments

Amneal Pharmaceuticals (NasdaqGS:AMRX) reported strong Q4 2025 results, highlighting progress across specialty, injectables, biosimilars, and complex generics. The company announced multiple product launches and regulatory approvals, expanding its presence in higher value segments. Management highlighted a promising pipeline, including biosimilars expected to enter the US market. Amneal also emphasized its collaboration with Pfizer on GLP-1 therapies as a key focus area for future...
NYSE:HD
NYSE:HDSpecialty Retail

Is Home Depot (HD) Still Attractively Priced After Housing Bellwether Spotlight?

If you are wondering whether Home Depot at around US$380 is still a solid entry or starting to look expensive, you are not alone. The stock last closed at US$380.72, with returns of 1.6% over 30 days, 10.1% year to date and 69.6% over 5 years, while the 1 year return is a 1.6% decline and the 3 year return is 37.7%. Recent news coverage has focused on Home Depot's role as a bellwether for US housing and renovation trends, and what that might mean for longer term demand. At the same time,...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Caris Life Sciences Advances Early Detection And AI Tools As Valuation Lags

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...